Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Cryonics organization
|
| gptkbp:advocacy |
Public awareness campaigns
Scientific research funding Legal recognition of cryonics |
| gptkbp:affiliation |
gptkb:Cryonics_Institute
gptkb:American_Cryonics_Society |
| gptkbp:collaborations |
Universities
Biotechnology companies Medical research organizations |
| gptkbp:community |
Cryonics community
Life extension community Transhumanist community |
| gptkbp:conservationEfforts |
Vitrification
Cryoprotectant infusion |
| gptkbp:criticism |
Ethical concerns
Public perception Financial viability Scientific skepticism |
| gptkbp:founded |
1972
|
| gptkbp:founder |
Fred Chamberlain
|
| gptkbp:future_plans |
Increase membership
Expand research initiatives Develop new preservation technologies Enhance public outreach |
| gptkbp:goal |
Preservation of identity
Life extension |
| gptkbp:headquarters |
gptkb:Scottsdale,_Arizona
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alcor
|
| gptkbp:legal_representation |
Non-profit organization
|
| gptkbp:membership |
Alcor_members
|
| gptkbp:notable_event |
Partnerships with research institutions
Expansion of facilities in 2016 First patient cryopreserved in 1976 Increased media coverage in the 2000s Legal battles over cryonics |
| gptkbp:notablePerson |
gptkb:Timothy_Leary
gptkb:Max_More gptkb:Robert_Ettinger |
| gptkbp:publications |
Cryonics magazine
Alcor_News |
| gptkbp:research_focus |
Neuroscience
Cryobiology |
| gptkbp:revenue |
Donations
Membership fees Cryopreservation contracts |
| gptkbp:services |
Cryonics
Cryopreservation |
| gptkbp:technology |
Cryonic_revival
Cryonic_suspension |
| gptkbp:type |
Cryonics provider
|
| gptkbp:website |
www.alcor.org
|